A nurse is teaching a clientwho has uncontrolled asthma about the ...

[bio_gurl]

A nurse is teaching a clientwho has uncontrolled asthma about the addition of two new medications. Cromolyn and montelukast (Singulair) have been added. The client asks why these medications were added. What is the nurse's best response?
 
  1. They are used as second-line drugs for the treatment of asthma.
  2. Both work together in a synergist approach.
  3. The prescriber is discontinuing the albuterol (Proventil) and ipratropium (Atrovent).
  4. The prescriber is trying something new.

Question 2

A client is prescribed montelukast (Singulair), a leukotriene modifier. Which best describes why this medication was added to the treatment of the client's asthma?
 
  1. The medication is used for the prophylaxis of asthma.
  2. The medication is important for an acute bronchospasm.
  3. The medication has serious adverse effects including immunosuppression.
  4. The medication should not have been added to the treatment.

[Briannahope]

Answer to Question 1

1

Rationale 1: Leukotriene modifiers and mast cell stabilizers are added as second-line drugs for the treatment of asthma.
Rationale 2: These drugs do not work synergistically.
Rationale 3: The medications were added and there was no indication that the other medications would be discontinued.
Rationale 4: These medications are often added as second-line drugs.

Global Rationale: The mast cell stabilizers and leukotriene modifiers are second-line drugs for the treatment of asthma. These drugs are prescribed when bronchodilators and corticosteroids are unable to control asthma symptoms.

Answer to Question 2

1

Rationale 1: Leukotriene modifiers are added to reduce inflammation and ease bronchoconstriction by modifying the action of the leukotrienes, which are mediators of the inflammatory response.
Rationale 2: Leukotriene modifiers are not used in an acute bronchospasm.
Rationale 3: Leukotriene modifiers have adverse effects of headache, cough, nasal congestion, GI upset, and psychiatric effects such as depression and suicidal thinking.
Rationale 4: Leukotriene modifiers are added for the treatment of asthma that cannot be controlled by bronchodilators and corticosteroids.

Global Rationale: Leukotriene modifiers are added to the treatment of asthma when bronchodilators and corticosteroids are unable to. Leukotriene modifiers are added to reduce inflammation and ease bronchoconstriction by modifying the action of the leukotrienes, which are mediators of the inflammatory response. Leukotriene modifiers have adverse effects of headache, cough, nasal congestion, GI upset, and psychiatric effects such as depression and suicidal thinking.

[bio_gurl]

TY

[Briannahope]

You're welcome